Wednesday, December 3, 2008 - 1:25AM EST

Review Articles

41. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

Author
Baccarani M; Saglio G; Goldman J; Hochhaus A; Simonsson B; Appelbaum F; Apperley J; Cervantes F; Cortes J; Deininger M; Gratwohl A; Guilhot F; Horowitz M; Hughes T; Kantarjian H; Larson R; Niederwieser D; Silver R; Hehlmann R;
Institution
Department of Hematology-Oncology L. and A. Seragnoli, S. Orsola-Malpighi Hospital, Via Massarenti 9, 40138 Bologna, Italy. baccarani@med.unibo.it
Journal
Blood. 2006 Sep 15;108(6):1809-20. Epub 2006 May 18.
Abstract URL
Click here to view abstract

42. Hearing loss in chronic myeloid leukemia.

Author
Naithani, Rahul; Chandra, Jagdish; Mathur, N N; Narayan, Shashi; Singh, Varinder;
Institution
Division of Hematology, Department of Pediatrics, Kalawati Saran Children's Hospital, New Delhi 110001, India. dr_rahul6@hotmail.com
Journal
Pediatr Blood Cancer 2005 Jul;45(1):54-6.
Abstract URL
Click here to view abstract

43. Targeted cancer therapies.

Author
Blay, Jean-Yves; Le Cesne, Axel; Alberti, Laurent; Ray-Coquart, Isabelle;
Institution
Inserm Unit 590, Centre Leon Berard, 28 rue Laennec, 69008 Lyon, France. blay@fnclcc.lyon.fr
Journal
Bull Cancer 2005 Feb;92(2):E13-8.
Abstract URL
Click here to view abstract

44. Targeting the silent minority: emerging immunotherapeutic strategies for eradication of malignant stem cells in chronic myeloid leukaemia.

Author
Copland, M; Fraser, A R; Harrison, S J; Holyoake, T L;
Institution
ATMU, Section of Experimental Haematology, University Faculty of Medicine, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow, G31 2ER, UK.
Journal
Cancer Immunol Immunother 2005 Apr;54(4):297-306. Epub 2004 Nov 30.
Abstract URL
Click here to view abstract

45. The development of imatinib as a therapeutic agent for chronic myeloid leukemia.

Author
Deininger, Michael; Buchdunger, Elisabeth; Druker, Brian J;
Institution
Oregon Health & Science University Cancer Institute, 3181 SW Sam Jackson Park Rd, Mailcode L592, Portland, OR 97239, USA. deininge@ohsu.edu
Journal
Blood 2005 Apr 1;105(7):2640-53. Epub 2004 Dec 23.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5